GlassScriptPhysician profile
Ray H Kim
NPI 1821017799
$21,007.21
in general payments reported to CMS, 2019-2025
24 companies · $11K in 2025
The $11K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,073 · 2020: $1,969 · 2021: $2,785 · 2022: $1,728 · 2023: $431 · 2024: $1,292 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,175 · Travel and Lodging: $3,348 · Food and Beverage: $2,928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,175.00 |
| Travel and Lodging | $3,348.44 |
| Food and Beverage | $2,928.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $10,013.32 | 2020-2025 | |
| Stryker Corporation | $2,927.40 | 2019-2025 | Prostep, Prostep Mica, Infinity Adaptis |
| Paragon 28, INC. | $2,382.66 | 2019-2024 | Precision Mis Bunion |
| Horizon Therapeutics Plc | $1,194.84 | 2019-2022 | |
| Crossroads Extremity Systems, LLC | $1,019.16 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $644.85 | 2019-2025 | Jublia, Arazlo, Cabtreo |
| Zimmer Biomet Holdings, INC. | $577.76 | 2020-2022 | |
| Medshape, INC. | $541.96 | 2025 | Dynanail Hybrid |
| Trilliant Surgical LLC. | $307.00 | 2019-2025 | Minimally Invasive Bunion Plate, Left |
| Novastep INC. | $248.33 | 2022-2025 | Nexis |
| Bioventus LLC | $225.46 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Abbott Laboratories | $208.15 | 2024-2025 | Esprit, Supera |
| Wright Medical Technology, INC. | $194.50 | 2019-2020 | |
| Sebela Pharmaceuticals INC. | $148.40 | 2019-2023 | Naftin |
| Ani Pharmaceuticals, INC. | $141.29 | 2025 | Oxistat |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $43.62 | 2023 | Collagenase Santyl, Regranex |
| Alfasigma USA, INC. | $34.63 | 2021 | |
| Depuy Synthes Sales INC. | $32.93 | 2024-2025 | |
| Ets Wound Care LLC | $24.35 | 2023 | |
| Linvatec Corporation | $23.10 | 2024 | 5ms |
| Nabriva Therapeutics, Plc | $22.36 | 2022 | |
| Glenmark Therapeutics INC. | $22.00 | 2019 | |
| Abbvie INC. | $15.16 | 2025 | |
| Paratek Pharmaceuticals, INC. | $13.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ray Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.